Abstract
Background: The acute phase protein pentraxin 3 (PTX3) is a new biomarker of stroke severity and is a key regulator of oedema resolution and glial responses after cerebral ischaemia, emerging as a possible target for brain repair after stroke. Neurogenesi
Original language | English |
---|---|
Article number | 15 |
Journal | JOURNAL OF NEUROINFLAMMATION |
Volume | 12 |
DOIs | |
Publication status | Published - 24 Jan 2015 |
Profiles
-
Francisco Molina-Holgado
- School of Life and Health Sciences - Associate Professor
- Centre for Integrated Research in Life and Health Sciences
Person: Academic